venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 6
- 0 vs. Q4 2025
- Portfolio value
- $280.6M
- +$64.3M (+29.7%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,639,304 | $131.1M | 46.7% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 4,528,408 | $99.8M | 35.6% | −91,395−2.0% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 12,884,638 | $25.8M | 9.2% | +3,184,713+32.8% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 489,194 | $13.7M | 4.9% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 337,697 | $6.77M | 2.4% | 00.0% | Unchanged | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 531,337 | $3.42M | 1.2% | −117,170−18.1% | Reduced | History |